LC
GSK icon

Landaas & Company’s GSK GSK Stock Holding History

Landaas & Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-90
Closed -$5K – 169
2018
Q2 		$5K Buy
+90
New +$4.53K ﹤0.01% 300
2018
Q1 		– Sell
-87
Closed -$4K – 161
2017
Q4 		$4K Sell
87
-159
-65% -$7.34K ﹤0.01% 295
2017
Q3 		$13K Buy
+246
New +$12.5K 0.01% 232

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Landaas & Company's GSK Position: Q3 2018 in Review

Landaas & Company sold out of GSK (GSK) in Q3 2018, closing a stake of 90 shares — an estimated $5K sold.

Landaas & Company first reported a position in GSK in Q3 2017 and held it in 3 quarters. The position peaked at $13K in Q3 2017. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

  • Landaas & Company reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 90 GSK shares in Q3 2018, an estimated $5K.
  • Landaas & Company first reported a position in GSK in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's GSK position peaked at $13K in Q3 2017.
  • 787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.